Sell alert! Expert calls time on Corporate Travel and CBA shares

A leading expert expects CBA and Corporate Travel shares to face significant headwinds.

It may be time to sell those Corporate Travel Management Ltd (ASX: CTD) and Commonwealth Bank of Australia (ASX: CBA) shares.

That's according to Red Leaf Securities' John Athanasiou, who earlier this week issued a sell recommendation on both ASX travel stocks (courtesy of The Bull).

In morning trade today, CBA shares are changing hands for $149.07 each, down 0.8%. That sees shares in the S&P/ASX 200 Index (ASX: XJO) bank stock down 10.8% since this time last year, trailing the 1.6% 12-month losses posted by the benchmark index.

Now some of that underperformance will have been mitigated by the two fully franked CBA dividends, totalling $5.05 a share, that the big four bank paid out over the year. CBA shares trade on a 3.4% fully franked trailing dividend yield.

It's a bit of a more complicated picture for Corporate Travel Management shares, which only resumed trading on the ASX on 3 September. As you may be aware, Corporate Travel shares were suspended back in August 2025 following some material accounting errors.

Prior to the suspension, Corporate Travel shares were trading for $16.07. On 3 September, shares crashed 85.6% to close the day at $2.32 as frustrated investors overheated their sell buttons.

In morning trade today, the Corporate Travel share price stands at $2.32.

With those pictures in mind…

Sell written several times on board.

Image source: Getty Images

Time to exit CBA shares?

"CBA is Australia's highest quality major bank, but, in my view, quality doesn't always represent value," Red Leaf Securities' Athanasiou said.

Explaining his sell recommendation on CBA shares, Athanasiou noted:

Its premium valuation leaves limited room for disappointment as rising interest rates potentially slow credit growth and increase borrower stress. Investors could use the opportunity to take profits and consider better-value alternatives elsewhere in the banking sector.

Should I sell Corporate Travel shares?

Atop his bearish outlook on CBA shares, Athanasiou also issued as sell recommendation on Corporate Travel shares.

"CTD reported improved underlying earnings in fiscal year 2026," he said.

Indeed, the company reported a 4% year on year increase in revenue and other income to $670 million, with underlying earnings before interest, tax, depreciation and amortisation (EBITDA) up 36% to $114 million.

But that's not enough to keep this ASX share off Athanasiou's sell list.

"However, in my view, questions remain around historical customer remediation, governance, financial controls and funding requirements," he said.

Summarising his sell recommendation on Corporate Travel shares, he concluded:

In a company update on April 22, 2026, a review had found that UK customers were charged in excess of their contractual entitlement. On September 1, 2026, the company noted about 78 per cent of customer refunds had been agreed or were nearing finalisation.

In my view, the near term risk-reward equation remains unattractive.

Motley Fool contributor Bernd Struben has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended Corporate Travel Management. The Motley Fool Australia has positions in and has recommended Corporate Travel Management. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Broker Notes

Woman looking at her computer and pondering something.
Broker Notes

Barrenjoey tips this ASX financial stock to rise 73%

A new deal has impressed the analysts.

Read more »

Red buy button on an Apple keyboard with a finger on it.
Broker Notes

Expert names Woodside and CSL shares as top buys today

A leading expert says now is the time to buy CSL and Woodside shares. But why?

Read more »

A male sharemarket analyst sits at his desk looking intently at his laptop with two other monitors next to him showing stock price movements
Broker Notes

Buy, hold, sell: Telix Pharmaceuticals, Qualitas, Greatland Resources shares

Here's what Mark Gardner from MPC Markets thinks of these three ASX shares.

Read more »

Two brokers analysing the share price with the woman pointing at the screen and man talking on a phone.
Broker Notes

Buy, hold, sell: Premier Investments, New Hope, Xero shares

We review three fresh buy, hold, and sell calls from expert market analysts.

Read more »

Happy businessman fist pumping while looking at a tablet.
Broker Notes

Up 120%, is it too late to buy Codan shares?

Bell Potter thinks this high-flying stock could keep rising.

Read more »

Medical workers examine an x-ray or scan in a hospital laboratory.
Broker Notes

This ASX biotech could nearly triple in value Bell Potter says

A big development in the US is good news for this company.

Read more »

two cute young boys dressed in business suits sit amid a pile of papers with a calculator and adding machine looking very happy for themselves.
Broker Notes

Buy, hold, sell: Fortescue, Westpac, CSL shares

One of these ASX shares is forecast to climb another 9% over the next 12 months.

Read more »

Woman working on her laptop at a café.
Broker Notes

Buy, hold, sell: Woodside, Life360, Ramsay Health Care shares

New stock tips for investors this week.

Read more »